CLINICAL_TRIALS
trial_result
· 2023-09-06
Clinical Trial Update: Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332 [Phase 1]
Summary
Phase 1 study assessing how hepatic impairment affects the pharmacokinetics of PF-07321332 has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hepatic Impairment | Phase 1 | Status: COMPLETED | Results posted: 2023-09-06